Gene · 3423
Papers1,392
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,392
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Boolean Modeling of Biological Network Applied to Protein-Protein Interaction Network of Autism Patients. | Biology (Basel) | 2024 | 39194544 | PubTator, text mining | PubMed |
| Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. | BioDrugs | 2024 | 39177874 | PubTator, text mining | PubMed |
| [Clinical phenotype, genetic characteristics, and creation of immortalized cell lines for patients from a pedigree affected with Hunter syndrome]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39097272 | PubTator, text mining | PubMed |
| Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy. | Mol Ther Methods Clin Dev | 2024 | 38946936 | PubTator, text mining | PubMed |
| Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer. | NPJ Precis Oncol | 2024 | 38783045 | PubTator, text mining | PubMed |
| Utilidad clínica de los biomarcadores óseos: un desafío a la variabilidad. | Adv Lab Med | 2024 | 38634078 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc. | Cell Death Dis | 2024 | 38627369 | PubTator, text mining | PubMed |
| Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier. | Pharmaceutics | 2024 | 38543255 | PubTator, text mining | PubMed |
| Transcriptome-informed identification and characterization of Planococcus citri cis- and trans-isoprenyl diphosphate synthase genes. | iScience | 2024 | 38523795 | PubTator, text mining | PubMed |
| Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II. | Orphanet J Rare Dis | 2024 | 38462612 | PubTator, text mining | PubMed |
| Analysis of caregiver perspectives on patients with mucopolysaccharidosis II treated with pabinafusp alfa: results of qualitative interviews in Japan. | Orphanet J Rare Dis | 2024 | 38454486 | PubTator, text mining | PubMed |
| Identification of new variants in patients with mucopolysaccharidosis in consanguineous Iranian families. | Front Genet | 2024 | 38425718 | PubTator, text mining | PubMed |
| Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model. | Cell Biochem Funct | 2024 | 38332678 | PubTator, text mining | PubMed |
| An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II. | Mol Ther | 2024 | 38310355 | PubTator, text mining | PubMed |
| The effectiveness of expanded carrier screening based on next-generation sequencing for severe monogenic genetic diseases. | Hum Genomics | 2024 | 38297315 | PubTator, text mining | PubMed |
| Toward grouped-reservoir computing: organic neuromorphic vertical transistor with distributed reservoir states for efficient recognition and prediction. | Nat Commun | 2024 | 38272878 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. | Int J Mol Sci | 2024 | 38256186 | PubTator, text mining | PubMed |
| Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases. | Biology (Basel) | 2024 | 38248465 | PubTator, text mining | PubMed |
| A close-up view of the Hunter syndrome. | Biochem Biophys Res Commun | 2024 | 38241811 | PubTator, text mining | PubMed |
| Identification of potential crucial genes and therapeutic targets for epilepsy. | Eur J Med Res | 2024 | 38212777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3423/papers?page=5